These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Detection and impact of hyperfibrinolysis in trauma. Schöchl H; Voelckel W; Solomon C Wien Klin Wochenschr; 2010 Dec; 122 Suppl 5():S11-3. PubMed ID: 21598439 [No Abstract] [Full Text] [Related]
47. [Blind spots of the diagnostic hemostasis screen]. Levi M; Peters M; Briët E Ned Tijdschr Geneeskd; 2000 Mar; 144(10):457-60. PubMed ID: 10726152 [TBL] [Abstract][Full Text] [Related]
48. [Use of antifibrinolytic agents in obstetrics]. Vojta M Cesk Gynekol; 1970 Jul; 35(6):384-6. PubMed ID: 5311001 [No Abstract] [Full Text] [Related]
49. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders]. Bokarev IN; Butorov VN; Loginov LE Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714 [No Abstract] [Full Text] [Related]
50. [Clinical studies on alpha 2-macroglobulin. Serum antifibrinolytic activity and alpha 2-macroglobulin]. Ando H Nihon Naika Gakkai Zasshi; 1970 Apr; 59(4):329-39. PubMed ID: 5462888 [No Abstract] [Full Text] [Related]
51. [Determination of serum inhibitors of fibrinolysis by the method of "standard clots"]. Daver J; Albugues MJ; du Pasquier JP; Ricoeur M Pathol Biol (Paris); 1970; 18(11):687-94. PubMed ID: 4247466 [No Abstract] [Full Text] [Related]
52. [Hemorrhages caused by hyperfibrinolysis and their treatment]. Teofili MT; Tucci G Clin Ter; 1968 Sep; 46(6):563-84. PubMed ID: 4914362 [No Abstract] [Full Text] [Related]
53. [Thromboplastic and fibrinolytic activity of the tissues of pregnant uterus and the elements of fertilized ovum]. Vdovina GF; Skipetrov VP; Azbukina LN Vopr Okhr Materin Det; 1975 Jun; 20(6):75-9. PubMed ID: 1136329 [No Abstract] [Full Text] [Related]
54. [Clinical usefulness of the measurements of plasmin-alpha 2-plasmin inhibitor complex and plasma tissue factor activity in patients with disseminated intravascular coagulation]. Fukuda C; Iijima K; Nakamura K Rinsho Byori; 1996 Aug; 44(8):750-6. PubMed ID: 8816061 [TBL] [Abstract][Full Text] [Related]
55. Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma. Nielsen VG; Kirklin JK; George JF Blood Coagul Fibrinolysis; 2009 Sep; 20(6):448-55. PubMed ID: 19581800 [TBL] [Abstract][Full Text] [Related]
56. [Experimental studies and clinical observations on the antifibrinolytic and hemostyptic effect of Epsilon-Tachostypan]. Egli H; Schröder F Dtsch Zahn Mund Kieferheilkd Zentralbl Gesamte; 1968 May; 50(9):386-404. PubMed ID: 5252696 [No Abstract] [Full Text] [Related]
57. [Antifibrinolytic agents and anticoagulants in disseminated intravascular coagulation, with particular regard to embolism of the amniotic fluid and hemorrhage in gynecology]. Koutský J Cesk Gynekol; 1971 Apr; 36(3):140-1. PubMed ID: 5314511 [No Abstract] [Full Text] [Related]